B. Argenteri

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data

G. Barbarini, S. Di Giambenedetto, A. di Biagio, 2018, The Annals of pharmacotherapy.

Pandemic influenza vaccine in adult HIV-1-infected patients.

E. Pariani, E. Tanzi, A. Zanetti, 2010, AIDS.

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

G. Barbarini, S. Di Giambenedetto, A. di Biagio, 2016, PloS one.

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.

M. Clerici, M. Biasin, D. Trabattoni, 2011, Blood.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.